CytoSorbents Corporation (CTSO)

[techxen]

Rapid treatment of unexpected septic shock
Cytosorb continues to be used in some extraordinary cases involving pediatric patients. In this case it was an 11 month old child:

Rapid treatment of unexpected septic shock: a single pediatric case recovery for Septic Shock due to Streptococcal Arthritis using early extracorporeal cytokine adsorber treatment
Raimondo P; Ficarella M; Moliterni P; Sisto M; Cito F; Calabrese G; Milella L; Pediatric Department of Anesthesia and Intensive Care Unit (General and Post Cardiac Surgery) Paediatric Hospital Giovanni XXIII – Bari, Italy

"We present a case of a male patient, aged 11 months, hospitalized in our Pediatric Hospital Giovanni XXIII (Bari, Italy) and evaluated by orthopedist at admission for a huge right knee edema, caused by ß-HemolyticStreptococcus and Staphylococcus Aureus and developed in septic shock within 12 hours after the admission. The patient was transferred to Pediatric ICU, in pre-agonal conditions, not responding to septic shock conventional treatments.

After parental consent, we added the extracorporeal cytokine absorber treatment (Cytosorb) to therapy, as life saving treatment. After two sets of 18 hours, we obtained a massive reduction of inflammatory mediators (IL-6, IL-10 and TNFa), an improvement of PRISM III and SOFA Score, a decrease of cathecolaminic support and an improvement of respiratory and metabolic parameters. After 5 days, the patient was transferred to the pediatric ward."

http://www.purificationtherapies.com/wp-content/uploads/01/16-2/P37_Poster_CYTO_Milella_Case%20report%20pediatrico.pdf